Skip to main content

Table 4 Biochemical parameters at genotyping. Mean and 95% confidence intervals of all readings taken within 2 years prior to enrolment in study

From: Association of common variation in the PPARAgene with incident myocardial infarction in individuals with type 2 diabetes: A Go-DARTS study

 

L162V

 

L/L

L/V

V/V

BMI

30.5

30.2–30.7

30.7

30.0–31.4

28.9

26.0–31.9

SBP mmHg

142.5

141.7-141.3

141.3

139.3–143.3

134.9

126.7–143.1

DBP mmHg

79.5

79.1–79.8

79.7

78.6–80.7

77.3

73.1–81.5

Cholrat† mmol/L

4.5

4.4–4.6

4.8

4.5–5.0

4.3

3.3–5.3

Chol mmol/L

5.2

5.2–5.3

5.3

5.1–5.4

5.3

4.8–5.8

Trigs mmol/L

2.7

2.6–2.8

2.8

2.6–3.1

2.4

1.3–3.5

HDL mmol/L

1.22

1.20–1.24

1.23

1.20–1.28

1.31

1.13–1.50

LDL mmol/L

2.89

2.84–2.92

2.89

2.78–3.00

2.92

2.42–3.41

 

G2528C

 

G/G

G/C

C/C

BMI

30.5

30.2–30.8

30.4

29.9–30.8

31.40

30.1–32.7

SBP mmHg

142.5

141.7–143.4

142

140.7–143.3

140.2

135.5–143.9

DBP mmHg

79.5

79.0–79.9

79.7

79.0–80.3

78.2

76.3–80.1

Cholrat† mmol/L

4.49

4.37–4.60

4.74

4.57–4.91

4.51

4.03–4.98

Chol mmol/L

5.20

5.15–5.25

5.26

5.18–5.34

5.56

5.33–5.79*

Trigs mmol/L

2.73

2.62–2.83

2.75

2.59–2.91

2.65

2.18–3.12

HDL mmol/L

1.22

1.20–1.24

1.23

1.20–1.25

1.25

1.17–1.34

LDL mmol/L

2.88

2.83–2.92

2.88

2.81–2.95

3.22

3.01–3.44*

  1. *P < 0.05 ANOVA co-dominant model
  2. † Cholrat = Total cholesterol/HDL Ratio